Document:

EX-10.1

 Exhibit 10.1 
 VIASAT, INC. 
 1996 EQUITY PARTICIPATION PLAN 

PERFORMANCE STOCK OPTION AGREEMENT 
  

							
	Grant:              “Target” Number of Options	 		  	Name:                             
                                         
 
			
	                  “Maximum” Number of
Options
	 		  	
			
	Grant
Date:                                       
                             	 		  	Signature:                            
                                     
			
	Exercise Price Per Share:
$                                        
  	 		  	Expiration Date:                           
                            
			
	Type of Option: Non-Qualified Stock Option	 		  	

 ACCEPTANCE OF AWARD: 
 By signing where indicated above, you agree to be bound by the terms and conditions of this Performance Stock Option Award Agreement (the “Agreement”) and the 1996 Equity Participation Plan
of ViaSat, Inc. (as amended from time to time, the “Plan”). You acknowledge that you have reviewed and fully understand all of the provisions of this Agreement and the Plan, and have had the opportunity to obtain advice of
counsel prior to accepting the grant of Options pursuant to this Agreement. You hereby agree to accept as binding, conclusive and final all decisions or interpretations of the Compensation and Human Resources Committee of the Board (the
“Committee”) upon any questions relating to this Agreement and the Plan. 

 TERMS AND CONDITIONS OF OPTION AWARD: 

1.    Grant of Option. 
 (a)    Grant of Option. In consideration of your past and/or continued employment with or service to ViaSat, Inc. (the “Company”) or a Subsidiary and for other
good and valuable consideration, effective as of the Grant Date, the Company grants to you the Option to purchase any part or all of an aggregate of the number of shares of Common Stock set forth in this Agreement, and upon the terms and conditions
set forth in the Plan and this Agreement. For the avoidance of doubt, the Option covers the “Maximum” Number of Options set forth in this Agreement, subject to the vesting and forfeiture provisions contained herein. The Option is a Non-Qualified Stock Option. 
 (b)    Exercise Price. The exercise price of
the shares of Common Stock subject to the Option shall be as set forth on the first page of this Agreement, without commission or other charge. 
 2.    Vesting and Exercisability. 
 (a)    Vesting
and Exercisability. Subject to Sections 2(b), and 8, the Option shall become vested and exercisable in such amounts and at such times as are set forth in Exhibit A. The Performance-Vested Options (as defined in Exhibit A) shall be
exercisable on and after the Certification Date (as defined in Exhibit A) but only to the extent the Performance-Vested Options are then also Time-Vested Options (or as and when the Performance-Vested Options also become Time-Vested Options
thereafter) as provided in Exhibit A. Notwithstanding anything to the contrary in this Agreement or Exhibit A, in no event may the Option be exercised prior to the Certification Date (as defined in Exhibit A). 

(b)    Expiration of Option. Subject to Section 10.3 of the Plan, the Option may not be exercised to any extent by
anyone after the first to occur of the following events: 
 (i)    The expiration of six years from the Grant Date;

 (ii)    The expiration of three months following the date of your Termination of Service (as defined below),
unless such termination occurs by reason of your death, Permanent Disability (as defined below) or discharge for Cause (as defined below), or you die within said three-month period; provided, however, that, if such termination occurs prior to
the Certification Date, that portion of your Performance-Vested Options that are Time-Vested Options as of the date of your Termination of Service shall remain exercisable until the date that is three months following the Certification Date;

 (iii)    The expiration of one year following the date of your Termination of Service if your termination is by
reason of your death or Permanent Disability (as defined below) or you die within the three-month period following your Termination of Service; provided, however, that, if such termination occurs prior to the Certification Date, that portion
of your Performance-Vested Options that are Time-Vested Options as of the date of your Termination of Service shall remain exercisable until the date that is three months following the Certification Date; or 

(iv)    The date of your Termination of Service as a result of your discharge for Cause; provided, however, if your
Termination of Service as a result of your discharge for Cause occurs after a Change in Control (as defined in Exhibit A), the period in this clause (iv) shall be thirty days following the date of your Termination of Service. 

  
 A-1 

 For purposes of this Agreement, “Termination of Service” means the last to
occur of your Termination of Consultancy, Termination of Directorship or Termination of Employment, as applicable. You shall not be deemed to have a Termination of Service merely because of a change in the capacity in which you render service to the
Company or any Subsidiary (i.e., you are an Employee and become a consultant) or a change in the entity for which you render such service (i.e., an Employee of the Company becomes an Employee of a Subsidiary), unless following such change in
capacity or service you are no longer serving as an Employee, Director or consultant of the Company or any Subsidiary. 
 For purposes of
this Agreement, “Permanent Disability” means that you are unable to perform your duties by reason of any medically determined physical or mental impairment which can be expected to result in death or which has lasted or is
expected to last for a continuous period of at least twelve (12) months, as reasonably determined by the Committee, in its discretion. 
 For purposes of this Agreement, “Cause,” unless otherwise defined in an employment or services agreement between you and the Company or any Subsidiary, shall mean your substantial failure to
perform duties as an Employee, Director or consultant, dishonesty, fraud, gross negligence or misconduct against the Company or any Subsidiary or affiliate, unauthorized use or disclosure of confidential information or trade secrets of the Company
or any Subsidiary or affiliate, or conviction of, or plea of nolo contendere to, a crime punishable by law (except misdemeanor violations), in each case as determined by the Committee, and its determination shall be final and binding.

 3.    Exercise of Option. 
 (a)    Partial Exercise. Subject to Section 2(a), any vested and exercisable portion of the Option or the entire Option, if then wholly vested and exercisable, may be exercised in
whole or in part at any time prior to the time when the Option or portion thereof becomes unexercisable under Section 2(b); provided, however, that each partial exercise shall be for not less than one share of Common Stock and
shall be for whole shares only. 
 (b)    Manner of Exercise. The Option, or any exercisable portion thereof,
may be exercised solely by delivery to the Secretary of the Company (or any third party administrator or other person or entity designated by the Company) of all of the following prior to the time when the Option or such portion thereof becomes
unexercisable under Section 2(b): 
 (i)    An Exercise Notice signed or electronically accepted by you or any
other person then entitled to exercise the Option or portion thereof, stating that the Option or portion thereof is thereby exercised, such notice in such form as is prescribed by the Committee and complying with all applicable rules established by
the Committee; and 
 (ii)    Subject to Section 5.2(d) of the Plan, the receipt by the Company of full payment
for the shares of Common Stock with respect to which the Option or portion thereof is exercised, which may be in one of the following forms of consideration: 
 (A)    By cash or check payable to the Company; or 

(B)    With the consent of the Committee, by delivery of shares of Common Stock then issuable upon exercise of the Option
having a Fair Market Value on the date of delivery equal to the aggregate exercise price of the Option or exercised portion thereof; or 

(C)    With the consent of the Committee such payment may be made, in whole or in part, through the delivery of shares of
Common Stock owned by you, duly endorsed for 

  
 A-2 

 
transfer to the Company with a Fair Market Value on the date of delivery equal to the aggregate exercise price of the Option or exercised portion thereof and held by you for such period of time
(if any) as may be necessary to avoid adverse accounting consequences; 
 (D)    Through the delivery of a notice
that you have placed a market sell order with a broker with respect to shares of Common Stock then issuable upon exercise of the Option, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company
in satisfaction of the Option exercise price; provided, that payment of such proceeds is made to the Company upon settlement of such sale; or 
 (E)    With the consent of the Committee, through the delivery of property of any kind which constitutes good and valuable consideration; or 

(F)    Subject to any applicable laws, any combination of the consideration provided in the foregoing paragraphs
(A) through (E); and 
 (iii)    Such representations and documents as the Committee, in its absolute
discretion, deems necessary or advisable to effect compliance with all applicable provisions of the Securities Act of 1933, as amended, and any other federal or state securities laws or regulations. The Committee or Board may, in its absolute
discretion, also take whatever additional actions it deems appropriate to effect such compliance including, without limitation, placing legends on share certificates and book entries and issuing stop-transfer notices to agents and registrars; and

 (iv)    The receipt by the Company of payment of any applicable withholding tax, which may be in the form of
consideration permitted under Section 3(b)(ii), subject to Section 3(d) below and Section 10.4 of the Plan; and 

(v)    In the event the Option or portion thereof shall be exercised by any person or persons other than you, appropriate
proof of the right of such person or persons to exercise the Option. 
 Notwithstanding any of the foregoing, the Committee shall have the
right to specify all conditions of the manner of exercise, which conditions may vary by country and which may be subject to change from time to time. 
 (c)    Rights as Stockholder; Issuance of Shares. Neither you nor any person claiming under or through you shall be, nor have any of the rights or privileges of, a stockholder of the
Company in respect of any shares purchasable upon the exercise of any part of the Option unless and until certificates representing such shares have been issued by the Company or book entries evidencing such shares have been made by the Company. The
issuance of shares of Common Stock pursuant to exercise of the Option is subject to the conditions set forth in Section 5.3 of the Plan. 
 (d)    Tax Withholding. 
 (i)    The Company has the
authority to deduct or withhold, or require you to remit to the Company, an amount sufficient to satisfy applicable Federal, state, local and foreign taxes (including any FICA obligation) required by law to be withheld with respect to any taxable
event arising from the vesting of the Option, the exercise of the Option and/or receipt of the shares of Common Stock upon exercise of the Option. 

  
 A-3 

 (ii)    The Company may refuse to honor the exercise of the Option and/or refuse
to issue any Common Stock upon exercise of your Option to you until your tax withholding obligations are satisfied. To the maximum extent permitted by law, the Company has the right to retain without notice from shares issuable under this Agreement
or from salary payable to you, shares or cash having a value sufficient to satisfy your tax withholding obligation. 

4.    Option Not Transferable. 
 (a)    The Option may not be sold, pledged, assigned or transferred in any manner other than by will or the laws of descent and distribution or pursuant to a QDRO, unless and until the shares
underlying the Option have been issued, and all restrictions applicable to such shares have lapsed. Neither the Option nor any interest or right therein shall be liable for the debts, contracts or engagements of you or your successors in interest or
shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any
other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by the preceding sentence. 

(b)    During your lifetime, only you may exercise the Option or any portion thereof, unless it has been disposed of pursuant
to a QDRO. After your death, any exercisable portion of the Option may, prior to the time when the Option becomes unexercisable under Section 2(b), be exercised by your personal representative or by any person empowered to do so under your will
or under the then applicable laws of descent and distribution. 
 5.    Restrictive Legends and Stop-Transfer
Orders. 
 (a)    Shares issued upon the exercise of the Option shall be issued to you, at the sole discretion of
the Committee, in either (i) uncertificated form, with the shares recorded in your name in the books and records of the Company’s transfer agent with appropriate notations regarding any restrictions imposed pursuant to this Agreement, or
(ii) certificate form. The share certificate or certificates or book entry evidencing the shares of Common Stock purchased hereunder shall be endorsed with any legends that may be required by state or federal securities laws. 

(b)    You agree that, in order to ensure compliance with the restrictions referred to herein, the Company may issue
appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records. 

(c)    The Company shall not be required: (i) to transfer on its books any shares of Common Stock that have been sold or
otherwise transferred in violation of any of the provisions of this Agreement, or (ii) to treat as owner of such shares of Common Stock or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such shares
shall have been so transferred. 
 6.    Notices. Any notice to be given under the terms of this Agreement to
the Company shall be addressed to the Company in care of the Secretary of the Company at the Company’s principal executive office, and any notice to be given to you shall be addressed to you at the most recent address in the Company’s
payroll records. By a notice given pursuant to this Section 6, either party may hereafter designate a different address for notices to be given to that party. Any notice which is required to be given to you shall, if you are then deceased, be
given to the person entitled to exercise the Option pursuant to Section 4(b) by written notice under this Section 6. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and
deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. 

  
 A-4 

 7.    Titles. Titles are provided herein for convenience only and are not
to serve as a basis for interpretation or construction of this Agreement. 
 8.    Conformity to Securities
Laws. You acknowledge that the Plan and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act and any and all regulations and rules promulgated by the Securities and
Exchange Commission thereunder, and state securities laws and regulations. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Option is granted and may be exercised, only in such a manner as to conform to such
laws, rules and regulations. To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such laws, rules and regulations. 

9.    Amendments. This Agreement may not be modified, amended or terminated except by a written instrument, signed or
electronically accepted by you or such other person as may be permitted to exercise the Option pursuant to Section 4(b) and by a duly authorized representative of the Company. 

10.    Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple
assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Agreement shall be binding upon you and your heirs, executors, administrators,
successors and assigns. 
 11.    Limitations Applicable to Section 16 Persons.
Notwithstanding any other provision of the Plan or this Agreement, if you are subject to Section 16 of the Exchange Act, the Plan, the Option and this Agreement shall be subject to any additional limitations set forth in any applicable
exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by
applicable law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule. 

12.    Entire Agreement. The Plan and this Agreement constitute the entire agreement of the parties and supersede in
their entirety all prior undertakings and agreements of the Company and you with respect to the subject matter hereof. 

13.    No Effect on Employment. Nothing in the Plan or this Agreement shall be interpreted to interfere with or limit in
any way the right of the Company or any Subsidiary to terminate your employment or services at any time, nor confer upon you the right to continue in the employ or service of the Company or any Subsidiary. 

14.    Plan Governs. This Option award is granted under and governed by the terms and conditions of the Plan. You
acknowledge and agree that the Plan has been introduced voluntarily by the Company and in accordance with its terms it may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time. The grant of Options under the Plan
is a one-time benefit and does not create any contractual or other right to receive an award of Options or benefits in lieu of Options in the future. Future awards of Options, if any, will be at the sole
discretion of the Company, including, but not limited to, the timing of the award, the number of shares and vesting provisions. By execution of this Agreement, you consent to the provisions of the Plan and this Agreement. Defined terms used herein
shall have the meaning set forth in the Plan, unless otherwise defined herein. 

  
 A-5 

 15.    Governing Law and Venue. 

(a)    The Option grant and the provisions of this Agreement are governed by, and subject to, the laws of the State of
California, without regard to the conflict of law provisions, as provided in the Plan. 
 (b)    For purposes of any
action, lawsuit or other proceedings brought to enforce this Agreement, relating to it, or arising from it, the parties hereby submit to and consent to the sole and exclusive jurisdiction of the courts of San Diego County, California, or the
federal courts for the United States for the Southern District of California, and no other courts, where this grant is made and/or to be performed. 
 16.    Electronic Delivery and Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic
means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third
party designated by the Company. 
 17.    Severability. The provisions of this Agreement are severable, and if
any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable. 

18.    Imposition of Other Requirements. The Company reserves the right to impose other requirements on your
participation in the Plan, on the Option and on any shares of Common Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require you to sign any additional
agreements or undertakings that may be necessary to accomplish the foregoing. 
 19.    Waiver. You acknowledge
that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by you or any other Grantee. 

  
 A-6 

 EXHIBIT A 
 VESTING AND EXERCISABILITY SCHEDULE 
 Capitalized terms used in this Exhibit A and not
defined in Section 5 below shall have the meanings given them in the Agreement to which this Exhibit A is attached. 

1.    Options Must Be Vested and Exercisable. You shall be able to exercise your Options but only to the extent such
Options have both (a) become Performance-Vested Options (as defined below) on and after the Certification Date pursuant to performance vesting in Section 3, and (b) Time-Vested Options (as defined below) pursuant to the time-based
vesting in Section 2 (or if not then vested on such Certification Date, as and when such Performance-Vested Options become Time-Vested Options thereafter pursuant to the time-based vesting in Section 2). 

2.    Time-Based Vesting. Subject to the conditions and limitations on exercisability of the Option award set forth in
Section 3 below, such percentage of the Performance-Vested Options shall also be considered “Time-Vested Options” as is determined pursuant to this Section 2: 

(a)    Time-Based Vesting. Subject to clauses 2(b) and 2(c) below, twenty-five percent (25%) of those Options that
become Performance-Vested Options, if any, shall become Time-Vested Options on each of the first four anniversaries of the Grant Date, subject to your continued employment or service with the Company or a Subsidiary through each applicable vesting
date. 
 (b)    Effect of Termination Due to Death or Permanent Disability. Notwithstanding Section 2(a)
above, in the event of your Termination of Service as a result of your death or Permanent Disability, one hundred percent (100%) of the Performance-Vested Options, if any, shall become Time-Vested Options and shall be vested and exercisable on the
Certification Date (or, if such Termination of Service occurs after the Certification Date, on the date of your Termination of Service). 

(c)    Effect of Other Terminations. Notwithstanding Section 2(a) above, in the event of your Termination of
Service for any reason other than your death or Permanent Disability, such percentage of the Performance-Vested Options, if any, as were Time-Vested Options pursuant to this Section 2 as of the date of your Termination of Service shall be
vested and exercisable on the Certification Date (or, if such Termination of Service occurs after the Certification Date, on the date of your Termination of Service) and no additional Options shall become Time-Based Options thereafter ;
provided, however, that the Option shall be subject to any accelerated vesting as may be provided in any employment or severance agreement between you and the Company, which accelerated vesting shall increase the percentage of Time-Vested Options, if any, under this Agreement. 
 3.    Performance
Vesting. Subject to the vesting provisions of Section 2 above and clauses (b) and (c) below, the Option shall be released from the restrictions on exercisability in this Agreement and shall become “Performance-Vested
Options” based on the Company’s Relative TSR Ranking for the Performance Period as follows: 

(a)    Measurement Date Occurs On October 31, [insert grant year + 4]. In the event the Measurement
Date is October 31, [insert grant year + 4], such number of Options shall be released from the restrictions on exercisability in this Agreement on the Certification Date by multiplying (i) the “Target” Number of Options subject
to this Option award, by (ii) the TSR Performance Multiplier determined as of the Measurement Date (rounded to the nearest whole share) (such number of Options, the “Performance-Vested Options”). 

  
 A-7 

 (b)    Measurement Date Occurs As a Result of Change in Control.

 (i)    Notwithstanding Section 3(a) above, in the event of a Change in Control prior to October 31,
[insert grant year + 4], the “Performance-Vested Options” shall be determined as of immediately prior to such Change in Control and shall be determined by multiplying (A) the “Target” Number of
Options subject to this Agreement, multiplied by (B) the greater of (1) one hundred percent (100%) or (2) the TSR Performance Multiplier as of the Measurement Date, as determined by the Committee and certified in writing immediately
prior to such Change in Control. 
 (ii)    In the event of a Change in Control on or after October 31, [insert
grant year + 4], if the Certification Date has not yet occurred prior to the date of such Change in Control, the “Performance-Vested Options” shall be determined as of immediately prior to such Change in
Control and shall be determined by multiplying equal to (A) the “Target” Number of Options subject to this Agreement, multiplied by (B) the TSR Performance Multiplier as of the Measurement Date. 

(iii)    In the event of a Change in Control prior to the date on which all of the Performance-Vested Options have also become
Time-Vested Options pursuant to Section 2 above, you shall continue to be eligible to vest in such Performance-Vested Options pursuant to Section 2 following the date of such Change in Control. 

4.    Forfeiture. Any portion of this Option award and any Options which do not become (or are no longer eligible to
become) Time-Vested Options and/or Performance-Vested Options as a result of your Termination of Service prior to the fourth anniversary of the Grant Date or as a result of less than the “Maximum” Number of Options subject to this Option
award becoming “Performance-Vested Options” by reason of the TSR Performance Multiplier being less than 175% shall automatically and without further action be cancelled and forfeited by you on the date of your Termination of Service or the
Measurement Date, as applicable, and you shall have no further right or interest in or with respect to such portion of this Option award. In no event will more than the “Maximum” Number of Options subject to this Option award vest and
become exercisable pursuant to this Exhibit A. 
 4.    Definitions. For purposes of this Exhibit
A, the following terms shall have the meanings given below: 
 (a)     “Beginning Market
Value” means, for each of the Company and the Peer Companies for the Performance Period, the average of the closing price per share of the company’s stock for the twenty (20) consecutive trading days beginning with and
including the first day of the Performance Period (or, if the first day of the Performance Period is not a trading day, the immediately preceding trading day) as published in The Wall Street Journal or such other authoritative source as the
Committee may determine. 
 (b)    “Certification Date” means the date on which the Committee
certifies the TSR Performance Multiplier, which certification shall occur no later than thirty (30) days following the Measurement Date; provided, however, that in the event the Measurement Date is the date of a Change in Control,
the Certification Date shall be the date of such Change in Control. 
 (c)    “Change in
Control” shall mean and include each of the following: 
 (i)     A transaction or series of
transactions (other than an offering of the Company’s Common Stock to the general public through a registration statement filed with the Securities and Exchange Commission) whereby any “person” or related “group” of
“persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act (other than the Company, any of its Subsidiaries, an employee benefit plan maintained by the Company or any of its Subsidiaries or a “person”
that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule
13d-3 under the Exchange Act) of securities of the Company possessing more than forty percent (40%) of the total combined voting power of the Company’s securities outstanding immediately after such
acquisition; 

  
 A-8 

 (ii)     The individuals who, as of the Grant Date are members of the Board (the
“Incumbent Board”), cease for any reason to constitute at least two-thirds of the members of the Board; provided, however, that if the election, or nomination for election
by the Company’s common stockholders, of any new director was approved by a vote of at least two-thirds of the Incumbent Board, such new director shall, for purposes of this definition, be considered as a
member of the Incumbent Board; provided, further, however, that no individual shall be considered a member of the Incumbent Board if such individual initially assumed office as a result of either an actual or threatened
“Election Contest” (as described in Rule 14a-11 promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board
(a “Proxy Contest”) including by reason of any agreement intended to avoid or settle any Election Contest or Proxy Contest; or 
 (iii)     The consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries) of (x) a merger, consolidation,
reorganization, or business combination or (y) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions or (z) the acquisition of assets or stock of
another entity, in each case other than a transaction: 
 (A)    Which results in the Company’s voting
securities outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Company or the person that, as a result of the transaction, controls, directly or
indirectly, the Company or owns, directly or indirectly, all or substantially all of the Company’s assets or otherwise succeeds to the business of the Company (the Company or such person, the “Successor Entity”))
directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and 
 (B)    After which no person or group beneficially owns voting securities representing forty percent (40%) or more of the combined voting power of the Successor Entity; provided,
however, that no person or group shall be treated for purposes of this Section 4(b)(iii)(B) as beneficially owning 40% or more of combined voting power of the Successor Entity solely as a result of the voting power held in the Company
prior to the consummation of the transaction. 
 The Board shall have full and final authority, which shall be exercised in its
discretion, to determine conclusively whether a Change in Control of the Company has occurred pursuant to the above definition, and the date of the occurrence of such Change in Control and any incidental matters relating thereto. 

(d)    “Ending Market Value” means, for each of the Company and the Peer Companies for the
Performance Period, (i) in the event the Measurement Date is October 31, [insert grant year + 4], the average of the closing price per share of the company’s stock for the last twenty (20) consecutive trading days ending with and
including the Measurement Date, or (ii) in the event the Measurement Date is the date of a Change in Control, the closing price per share of the company’s stock on the Measurement Date (or if the Measurement Date is not a trading day, the
immediately preceding trading day) as published in The Wall Street Journal or such other authoritative source as the Committee may determine. 
 (e)    “Measurement Date” means the first to occur of (a) October 31, [insert grant year + 4], or (b) the date on which a Change in Control occurs (or, in
each case, if such date is not a trading day, the immediately preceding trading day). 
 (f)    “Peer
Companies” means those companies included in the S&P Mid Cap 400 Index on the first day of the Performance Period (or if the first day of the Performance Period is not a trading day, the immediately preceding trading day) and
which remain publicly-traded and listed on a national securities exchange through the last day of the Performance Period (or if the last day of the Performance Period is not a trading day, the immediately preceding trading day). 

  
 A-9 

 (g)    “Performance Period” means the period beginning on
November 1, [insert grant year] and ending on the earlier to occur of (i) October 31, [insert grant year + 4], or (ii) the date of a Change in Control. 
 (h)    “Relative TSR Ranking” means the Company’s TSR relative to the TSRs of the Peer Companies. The Company’s Relative TSR Ranking will be
determined by ranking the Company and the Peer Companies from highest to lowest according to their respective TSRs. After this ranking, the percentile performance of the Company relative to the Peer Companies will be determined as follows:

 P = 1 – ((R-1)/(N-1)) 

 

	 	Where: “P”	represents the Company’s percentile performance, which will be rounded, if necessary, to the nearest whole percentile by application of regular rounding.

 “N” represents the number of Peer Companies. 

“R” represents the Company’s ranking among the Peer Companies. 

(i)    “TSR” means, with respect to the Performance Period, the total value delivered to stockholders
of the Company (or of a Peer Company, as applicable), as measured by the change in the price of the Common Stock of the Company (or common stock of a Peer Company, as applicable) over the Performance Period (positive or negative) from the Beginning
Market Value for the Performance Period to the Ending Market Value for such Performance Period, plus dividends paid over the Performance Period assuming dividends are reinvested based on the price of the Common Stock of the Company (or common stock
of a Peer Company, as applicable) on the last trading day of the month during which the ex-dividend date occurs. 
 (j)    The “TSR Performance Multiplier” means, for the Performance Period, the performance multiplier determined pursuant to the chart below based on the Company’s
Relative TSR Ranking. If the Company achieves a Relative TSR Ranking that falls between the foregoing levels, the Performance Multiplier will be determined by linear interpolation between the applicable levels. 

 

					
	 Relative TSR Ranking Relative to the S&P Mid Cap

400 for the Performance Period
	  	TSR Performance Multiplier	 
	 At or above the
90th Percentile
	  	 	175	% 
	 At the
80th Percentile
	  	 	160	% 
	 At the
70th Percentile
	  	 	140	% 
	 At the
60th Percentile
	  	 	120	% 
	 At the
50th Percentile
	  	 	100	% 
	 At the
40th Percentile
	  	 	80	% 
	 At the
30th Percentile
	  	 	60	% 
	 At or Below the
25th Percentile
	  	 	0	% 

  
 A-10EX-10.1

 EXHIBIT 10.1 

EXECUTION VERSION 
 THIRD AMENDMENT,
CONSENT AND LIMITED WAIVER TO CREDIT AGREEMENT AND 
 OTHER LOAN DOCUMENTS 

THIRD AMENDMENT, CONSENT AND LIMITED WAIVER TO CREDIT AGREEMENT AND OTHER LOAN DOCUMENTS (this “Amendment”) is entered into as of
February 12, 2018 among IBG Borrower LLC, a Delaware limited liability company (the “Borrower”), the Guarantors under the Agreement; each lender from time to time party hereto (collectively, the
“Lenders” and individually, a “Lender”); and Cortland Capital Market Services LLC, a Delaware limited liability company (“Cortland”) as Administrative Agent and Collateral Agent (Cortland,
together with its successors and assigns in such capacities, the “Agent”). 
 WHEREAS, the Borrower and the other Loan
Parties have entered into that certain Credit Agreement dated as of August 2, 2017, among the Borrower, the Guarantors, the Lenders and the Agent (as amended by that Limited Waiver and Amendment No. 1 dated as of October 27, 2017 and
that Second Amendment, Consent and Limited Waiver to Credit Agreement dated as of November 24, 2017 and as the same has been further amended, restated, amended and restated, supplemented or otherwise modified from time to time including by this
Amendment, the “Agreement”); 
 WHEREAS, the Borrower has requested that in accordance with the Agreement, the Agent and
the Required Lenders (A) consent to (x) (i) one or more exchanges of the 2018 Convertible Notes for 5.75% Convertible Senior Subordinated Secured Second Lien Notes due 2023 issued pursuant to those certain Exchange Agreements dated as of
the date hereof between certain holders of the 2018 Convertible Notes and Parent, each substantially in the form attached hereto as Exhibit A (collectively with such other public or private exchange agreements entered into from time to time relating
to the 2023 Notes Indenture and in substantially the same form as Exhibit A with such changes as are necessary to reflect the different economic terms or registered nature of such exchange, the “Exchange Agreement” and each, an
“Exchange Agreement”) and that certain Indenture in the form attached hereto as Exhibit B, and with such administrative changes as are necessary to complete information currently bracketed or blank in the form and which will not be
available until the exchange has been consummated (the “2023 Notes Indenture” and such notes, the “2023 Notes”) to be entered into by, among others, Parent, as company, certain subsidiaries of the Parent (including
the Borrower) as guarantors (collectively, the “Note Guarantors” and each, a “Note Guarantor”) and The Bank of New York Mellon Trust Company, N.A., a national banking corporation, as the trustee and collateral agent
(called together with its successors and assigns in such capacity, the “Second Lien Agent”), (ii) the entrance by the Loan Parties into the Note Documents (as defined in the 2023 Notes Indenture) including the Note Security
Documents and the Note Guarantees pursuant to which the Note Guarantors guarantee the Note Obligations (as defined in the 2023 Notes Indenture and each in substantially the same form as the corresponding document with respect to the Loans)
and grant a junior security interest to the Second Lien Agent for the benefit of the holders of the 2023 Notes in the same assets of the Loan Parties which secure the Loans under the Agreement and (iii) the Agent and the Loan Parties entering
into that certain Intercreditor Agreement in the form attached hereto as Exhibit C, and with such administrative changes as are necessary to complete information currently bracketed or blank in the form and which will not be available until the
exchange has been consummated (the “2023 Notes Intercreditor Agreement”) with the Second Lien Agent (such transactions called together with the amendment to the Organization Documents of the Parent solely to increase the number of
authorized shares and/or effect a reverse stock split in the manner required to facilitate such transactions in the manner contemplated in the Exchange Agreements (the “Parent Organization Document Amendments”), the “2023
Notes Exchange Transactions”) and (y) the dissolution of ICL-Badgley Mischka Limited (the “ICL Dissolution”) and (B) agree to make certain amendments and/or waive certain
provisions of the Agreement and the other Loan Documents solely as expressly set forth herein in order to facilitate (i) the 2023 Notes Exchange Transactions and the conversion rights described therein and (ii) the ICL Dissolution; 

 WHEREAS, Schedule 5.17 of the Agreement and Schedule 6 to the Security Agreement delivered on the
Closing Date included the Trademarks described in Exhibit D (the “Iconix China Trademarks”) that were contributed to Iconix China Limited (“Iconix China”) by certain of the Loan Parties in 2008 pursuant to
the terms of that certain Master Trademark Agreement dated as of September 5, 2008 entered into, by among others, certain of the Loan Parties and Iconix China and certain other effectuating transfer documents. The Iconix China Trademarks are
not and were not owned solely and exclusively by the Loan Parties at any time on or after the Closing Date as the Loan Parties represented in Section 5.17 of the Agreement and in Section 4(f) of the Security Agreement each time such
representations were made on and after the Closing Date (the “Specified Representations”) and as such the Borrower has requested that the Agent and the Required Lenders waive the Defaults and the related Event of Default under
Section 8.01(d) arising solely from such Specified Representations (the “Specified Defaults”) and consent to release their Liens on the Iconix China Trademarks and to make certain amendments to the Schedule 5.17 of the
Agreement and Schedule 6 to the Security Agreement to reflect the release of the Iconix China Trademarks; 
 NOW, THEREFORE, in
consideration of the premises set forth above and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned parties agree as follows: 

Section 1. Definitions. Except as otherwise defined in this Amendment, capitalized terms in
this Amendment have the meanings ascribed to such terms in the Agreement. This Amendment shall constitute a Loan Document for all purposes of the Agreement and the other Loan Documents. 

Section 2. Waiver and Consent. 

A. Consent to Entry Into Exchange Agreements and Parent Organization Document Amendments. Each of the Agent and
the Lenders signatory hereto hereby consent to the entry of the Loan Parties into the Exchange Agreements and the Parent Organization Document Amendments. 

B. Consent to 2023 Notes Exchange Transactions. Subject to the satisfaction of the conditions
precedent under Section 4, each of the Agent and the Lenders signatory hereto hereby consent to the 2023 Notes Exchange Transactions and the entry of the Loan Parties into the Notes Documents (including, the Note Security Documents and the Note
Guarantees) and agree that (a) such exchange transaction is a Permitted Capital Raising Transaction and that each dollar of 2018 Convertible Notes so exchanged shall count as a dollar raised in a Permitted Capital Raising Transaction for the
purpose of satisfying the condition precedent in Section 4.04(b) of the Agreement to the Second Delayed Draw Term Loan to raise $100,000,000 during the Delayed Draw Period and (b) the Liens granted pursuant to the Note Documents are
Permitted Encumbrances pursuant to clause (x) of such definition. For the avoidance of doubt, nothing in this Section 2A shall be deemed to waive any violation of the Credit Documents which would occur as a result of the performance of any
right or obligation of the Credit Parties or any other Person under the 2023 Note Documents from time to time. 
 C.
Consent to ICL Dissolution. Subject to the satisfaction of the conditions precedent under Section 4, each of the Agent and the Lenders signatory hereto hereby consent to the ICL Dissolution. 

 D. Waiver of Specified Defaults and Consent to Release of the Iconix China
Trademarks. Each of the Agent and the Lenders signatory hereto hereby consent to (i) waive the Specified Defaults and (ii) the release of the Iconix China Trademarks (the “Iconix China Release”). 

The waiver and consents set forth above shall be limited precisely as written and shall relate solely to the Specified Defaults in the manner
they exist on the date hereof and not to any other change in facts or circumstances occurring after the date hereof and shall not relate to any other Defaults or Events of Default now existing or occurring after the date hereof, and shall not in any
way or manner restrict the Agent or any Lender from exercising any rights or remedies they may have in respect of any Default or Event of Default (including, for the avoidance of doubt, any Default or Event of Default existing as of the date hereof
which is not a Specified Default) at any time in respect of the Agreement or any other Loan Document. Nothing herein shall be deemed to constitute a consent to any other departure from or a waiver of any other term, provision or condition of the
Agreement or any other Loan Document or prejudice any right or remedy that the Agent or any Lender may have or may in the future have. 

Section 3. Amendments to Agreement. Subject to the satisfaction of the terms and conditions set forth
in Section 4, the Agreement is hereby amended as of the Third Amendment Effective Date as follows: 

A. Section 1.01 of the Agreement is hereby amended by (i) deleting the definition of “Collateral
Questionnaire”, (ii) deleting the reference to the Collateral Questionnaire in the definition of “Loan Documents” and (iii) adding the following new defined terms in the appropriate alphabetical order: 

“2023 Convertible Notes” means the 5.75% Convertible Senior Subordinated Secured Second Lien Notes due 2023 issued pursuant to
that certain Indenture dated as of the Third Amendment Effective Date (as the same may be amended, restated, amended and restated, supplemented or otherwise modified from time to time in accordance with the terms hereof and the Intercreditor
Agreement, the “2023 Notes Indenture”) entered into by, among others, Parent, as company, certain subsidiaries of the Parent (including the Borrower) as guarantors (collectively, the “Note Guarantors” and each, a
“Note Guarantor”) and The Bank of New York Mellon Trust Company, N.A., a national banking corporation, as the trustee (called together with its successors and assigns in such capacity, the “Second Lien Notes
Trustee”) and collateral agent (called together with its successors and assigns in such capacity, the “Second Lien Agent”). 

“2023 Note Documents” means the “Note Documents” as defined in the 2023 Notes Indenture (as in effect on the Third
Amendment Effective Date and as the same may be amended, restated, amended and restated, supplemented or otherwise modified from time to time in accordance with the terms hereof and the Intercreditor Agreement). 

“2023 Notes Exchange Transactions” shall have the meaning given to such term in the Third Amendment.  

“Intercreditor Agreement” means that certain Intercreditor Agreement dated as of the Third Amendment Effective Date, entered
into by among others, the Agent, as first lien agent and the Second Lien Notes Trustee, as second lien notes trustee. 

 “Third Amendment” means that certain Third Amendment, Consent and Limited Waiver
to Credit Agreement and Other Loan Documents dated as of February 12, 2018 and entered into by, among others, the Loan Parties, the Agent and the Lenders. 

“Third Amendment Effective Date” shall mean the date on which all of the conditions precedent set forth in Section 4 to
the Third Amendment have been satisfied. 
 B. As of the Third Amendment Effective Date and after giving effect to the 2023
Exchange Transactions, clause (x) of the definition of “Permitted Encumbrances” in Section 1.01 of the Agreement is amended and restated as follows: 

 

	 	i.	(x) Liens securing Indebtedness permitted by clauses (j) and (s) of “Permitted Indebtedness” incurred during the Delayed Draw Period (or any Permitted Refinancing thereof in accordance with such
clauses); provided that such Liens are junior in priority to the Liens securing the Obligations and subject to a customary “silent” second lien intercreditor agreement in form and substance satisfactory to the Agent (acting at the
direction of the Required Lenders acting reasonably).”. 

 C. Section 7.06 (g) of the Agreement is
hereby deleted and replaced in its entirety with the following: 
 “(g) the Loan Parties and their Subsidiaries may make cash payments
in lieu of issuing fractional shares in connection with (i) the exercise of warrants, options or other securities convertible into or exchangeable for Equity Interests, of any such Person; provided that no such cash payments shall be
made pursuant to this clause (g) in respect of the 2023 Notes in excess of $1,000,000 in the aggregate for the term of this Agreement, or (ii) in connection with the issuance of any dividend otherwise permitted to be made under this
Section 7.06”. 
 D. Section 7.06 of the Agreement is hereby amended by: 

 

	 	i.	deleting the “or” at the end of clause (h); 

  

	 	ii.	deleting the “.” at the end of clause (i) and inserting “or” and the following: 

“(j) for each of the following clauses (x) and (y) to the extent permitted by the terms hereof, of the Intercreditor Agreement and
Article 6 of the 2023 Notes Indenture, any (x) payments of cash (paid by the Borrower or Parent) solely with respect to fractional shares not to exceed $1,000,000 in the aggregate and/or Equity Interest of Parent (other than Disqualified Stock)
to a holder (or for the benefit of the holder) of the 2023 Notes upon the conversion thereof in accordance with the terms thereof or (y) any payments of regularly scheduled cash interest in respect of the 2023 Notes. 

E. Section 7.07 of the Agreement is hereby amended by: 

 

	 	i.	deleting the “and” at the end of clause (d); 

  

	 	ii.	deleting the “.” at the end of clause (e) and inserting the following: 

	 	 	“, (f) regularly scheduled interest payments and payments of fees, expenses and indemnifications obligations in respect of the 2023 Notes when due and in amounts not to exceed amounts required to be paid with
respect thereto, and permitted under the Intercreditor Agreement, the terms hereof and Article 6 of the 2023 Notes Indenture and (g) payments with, or conversions to, Equity Interests of Parent (other than Disqualified Stock).”.

 F. Section 7.10 of the Agreement is hereby amended and restated in its entirety as follows: 

“7.10 Burdensome Agreements. Enter into or permit to exist any Contractual Obligation (other than this Agreement or any
other Loan Document) that (a) limits the ability (i) of any Subsidiary to make Restricted Payments or other distributions to any Loan Party or to otherwise transfer property to or invest in a Loan Party, (ii) of any Subsidiary to
Guarantee the Obligations, (iii) of any Subsidiary to make or repay loans to a Loan Party, or (iv) of the Loan Parties to create, incur, assume or suffer to exist Liens on property of such Person in favor of the Agent provided,
however, that (y) clause (a)(i) and clause (a)(iv) shall not prohibit (1) any negative pledge incurred or provided in favor of any holder of Indebtedness permitted under clause (d) of the definition of Permitted Indebtedness
solely to the extent any such negative pledge relates to the property financed by or the subject of such Indebtedness, (2) customary provisions restricting subletting or assignment of any lease entered into in the Ordinary Course of Business,
(3) customary provisions restricting assignment of any licensing entered into in the Ordinary Course of Business, (4) encumbrances or restrictions on deposits imposed by customers under agreements entered into in the Ordinary Course of
Business, (5) customary provisions in joint venture agreements and other similar agreements applicable to joint ventures permitted hereunder (other than any Loan Party) and applicable solely to such joint venture, (6) restrictions on the
transfer of any asset pending the close of the sale of such asset so long as such restriction applies only to such assets to be sold, (7) any agreement or instrument governing Indebtedness assumed in connection with a Permitted Acquisition, to
the extent the relevant encumbrance or restriction was not agreed to or adopted in connection with, or in anticipation of, the respective Permitted Acquisition and does not apply to any Loan Party or any Subsidiary of any Loan Party, or the property
of any such Person, other than the property acquired in such Permitted Acquisition, (8) restrictions set forth in the 2023 Notes Documents as in effect on the Third Amendment Effective Date, (9) restrictions imposed by any agreement
relating to Indebtedness permitted by this Agreement to be incurred after the Third Amendment Effective Date if the relevant restrictions, taken as a whole, are not materially less favorable to the Loan Parties or the Lenders than the restrictions
contained in this Agreement, taken as a whole, (10) customary provisions restricting assignment of any governmental contract entered into in the Ordinary Course of Business, and (z) clause (a) shall not prohibit restrictions incurred or
provided in favor of any holder of Indebtedness permitted under clause (r) of the definition of “Permitted Indebtedness”, solely to the extent any such restrictions relate to the applicable Available Amount Acquisition Target
and its Subsidiaries acquired in an Acquisition utilizing the Available Amount and or (b) requires the grant of a Lien to secure an obligation of such Person if a Lien is granted to secure another obligation of such Person, other than as set
forth in the 2023 Notes Documents as in effect on the Third Amendment Effective Date.” 

 G. Section 7.12(a)(i) of the Agreement is hereby amended and restated in
its entirety as follows: 
 “(i) Amend, modify, terminate or waive any of a Loan Party’s or a Subsidiary’s under (A)(1) other
than with respect to the Borrower, its Organization Documents in a manner materially adverse to the Credit Parties (in their capacities as such) and (2) with respect to the Borrower, its Organization Documents without the prior written consent
of Agent (acting at the direction of the Required Lenders), (B) any documentation relating to any Indebtedness for borrowed money that is unsecured or Subordinated Indebtedness that would, when taken as a whole, be materially adverse to the Credit
Parties (in their capacities as such) (provided that it is understood that any amendments, modifications and/or waivers to the 2023 Notes and the 2023 Note Documents that are permitted under the Intercreditor Agreement shall be permitted and shall
not be considered materially adverse to the interests of the Credit Parties), (C) any Material License which would have a material adverse impact on the Lenders (in their capacities as such) (as reasonably determined by the Agent), without the prior
express written consent of the Agent (acting at the direction of the Required Lenders) or (D) any Material Contract in a manner that would be materially adverse to the financial condition of the Parent, the Borrower or any of its
Subsidiaries.” 
 H. Section 10.06(b)(ii) of the Agreement is hereby deleted in its entirety. 

I. Certain disclosure schedules to the Agreement will be amended as may be agreed in writing by the Loan Parties and the
Required Lenders by supplemental schedules in form satisfactory to the Required Lenders and to be delivered to the Agent prior to the Third Amendment Effective Date. 

Section 4. Conditions Precedent. The consent and limited waivers set forth in
Section 2(B) and Section 2(C) and the amendments set forth Section 3 shall become effective, as of the date hereof, upon satisfaction of the following conditions (the
“Third Amendment Effective Date”): 
 (a) The Agent shall have received the following, each in form and substance
reasonably satisfactory to the Agent and the Required Lenders: 
 (i) a counterpart signature page of this Amendment duly
executed by the Borrower, the Guarantors, each Lender party to the Agreement and the Agent; 
 (ii) duly executed copies of
the Exchange Agreements to be dated as of the date hereof; 
 (iii) duly executed copies of the 2023 Notes Indenture, the
2023 Notes Intercreditor Agreement and each of the Note Security Documents to be entered into in connection therewith; and 

 (iv) a certificate of a Responsible Officer of the Parent addressed to the
Lenders, in form and substance satisfactory to the Lead Lender and certifying as to the matters specified therein. 
 (b) All accrued fees
and reasonable and documented expenses of the Agent and Lenders (including the reasonable and documented fees and expenses of external counsel (including Milbank, Tweed, Hadley & McCloy LLP and any local counsel to the Lead Lender and
Holland & Knight LLP and any local counsel to the Agent)) and invoiced to the Borrower at least one day prior to such date shall have been paid. 

Section 5. Reference to and Effect on the Agreement and the Loan Documents. On and after the
Third Amendment Effective Date, each reference in the Agreement or Loan Documents to “this Agreement”, “the Loan Documents”, “hereunder”, “hereof” or words of like import referring to the Agreement and each of
the other Loan Documents to “the Agreement”, “the Loan Documents”, “thereunder”, “thereof” or words of like import referring to the Agreement and/or the Loan Documents, shall mean and be a reference to the
Agreement and/or the Loan Documents, as amended by this Amendment. 
 Section 6. Representations and Warranties; Ratification of
Obligations. 
 The Loan Parties represent and warrant that (i) ICL-Badgley Mischka Limited does not
own any assets or property with a value in excess of $100,000 in aggregate and (ii) they do not (nor do any of their Subsidiaries or Securitization Entities) solely and exclusively own all right, title and interest in and to, or possess a valid
and enforceable license to use, all the Iconix China Trademarks set forth on Exhibit D. Further, after giving effect to the consents, amendments, supplements and modifications contained herein and in the supplemental schedules to the Agreement, the
supplementary schedules to the Security Agreement in connection herewith (collectively, the “Third Amendment Supplements”) and (a) (i) each of the representations and warranties set forth in Article V of the Agreement are true
and correct in all material respects on and as of the Third Amendment Effective Date, except to the extent that such representations and warranties expressly relate to an earlier date, in which case such representations and warranties remain true
and correct in all material respects as of such earlier date and, in the case of any of the foregoing, other than representations that are qualified by materiality, which are true and correct in all respects; (ii) no Default or Event of Default
has occurred and is continuing; and (iii) no event, change or condition has occurred that has had or could reasonably be expected to have, a Material Adverse Effect and (b) each Loan Party (i) confirms its Obligations (including any
guarantee obligation) under each Loan Document, in each case as amended, supplemented or modified after giving effect to this Amendment and the Third Amendment Supplements, (ii) confirms that its Obligations as amended, supplemented or modified
hereby under the Agreement are entitled to the benefits of the pledges and guarantees, as applicable, set forth in the Loan Documents, in each case, as amended, supplemented or modified after giving effect to this Amendment (including as such grants
have been amended, supplemented or modified by this Amendment and the Third Amendment Supplements), (iii) confirms that its Obligations under the Agreement constitute Obligations and (iv) agrees that the Agreement as amended, modified or
supplemented hereby is the Agreement under and for all purposes of the Agreement and the other Loan Documents. Each party, by its execution of this Amendment, hereby confirms that the Obligations shall remain in full force and effect (except as such
Obligations have been expressly supplemented, amended or modified hereby or by the Third Amendment Supplements), and such Obligations shall continue to be entitled to the benefits of the grant set forth in the Collateral Documents, as amended,
supplemented or modified hereby. 
 Section 7. Severability. Any provision of this Amendment held to
be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such 

 
invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions of this Amendment; and the invalidity of a particular provision
in a particular jurisdiction shall not invalidate such provision in any other jurisdiction. 
 Section 8.
Headings. Headings herein are for convenience only and shall not be relied upon in interpreting or enforcing this Amendment. 

Section 9. Miscellaneous. This Amendment may be executed in any number of counterparts, all of which
taken together shall constitute one and the same amendatory instrument and any of the parties hereto may execute this Amendment by signing any such counterpart. This Amendment and the rights and obligations of the parties hereunder (including any
claims sounding in contract law or tort law arising out of the subject matter hereof and any determinations with respect to post-judgment interest) shall be governed by, and shall be construed and enforced in accordance with, the laws of the State
of New York.  

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their
respective authorized officers as of the date first above written. 
  

							
	PARENT:	  		 		 	
			
		  		 	ICONIX BRAND GROUP, INC.,
		  		 	a Delaware corporation
				
		  		 	By:	 	 /s/ David Jones

		  		 	Name: David Jones
		  		 	Title: Chief Financial Officer
				
	BORROWER:	  		 		 	
			
		  		 	IBG BORROWER LLC,
		  		 	a Delaware limited liability company
				
		  		 	By:	 	 /s/ David Jones

		  		 	Name: David Jones
		  		 	Title: Chief Financial Officer

 [Signature Page to Third Amendment to Credit Agreement] 

 SUBSIDIARY GUARANTORS: 
  

									
	 ARTFUL HOLDINGS LLC,
 a
Delaware limited liability company
	 		 	 ICON ENTERTAINMENT LLC,
 a
Delaware limited liability company

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer
			
	 BADGLEY MISCHKA LICENSING LLC,

a Delaware limited liability company
	 		 	 ICON DE BRAND HOLDINGS CORP.,

a Delaware corporation

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer
			
	 BRIGHT STAR FOOTWEAR LLC,
 a
New Jersey limited liability company
	 		 	 ICONIX ECOM, LLC,
 a Delaware
limited liability company

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer
				
	 ICON CANADA JV HOLDINGS CORP.,

a Delaware corporation
	 		 		 	
					
	By:	  	 /s/ David Jones
	 		 		 	
	Name:	  	David Jones	 		 		 	
	Title:	  	Chief Financial Officer	 		 		 	

 [Signature Page to Third Amendment to Credit Agreement] 

 SUBSIDIARY GUARANTORS (continued): 

 

									
	 ICONIX CA HOLDINGS LLC,

a Delaware limited liability company
	 		 	 IP HOLDINGS UNLTD LLC,

a Delaware limited liability company

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer
			
	 ICONIX LATIN AMERICA LLC,

a Delaware limited liability company
	 		 	 IP MANAGEMENT LLC,

a Delaware limited liability company

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer
			
	 IP HOLDINGS AND MANAGEMENT CORPORATION,

a Delaware corporation
	 		 	 MICHAEL CARUSO & CO., INC.,

a California corporation

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer
			
	 IP HOLDINGS LLC,

a Delaware limited liability company
	 		 	 MOSSIMO HOLDINGS LLC,

a Delaware limited liability company

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer

 [Signature Page to Third Amendment to Credit Agreement] 

 SUBSIDIARY GUARANTORS (continued): 

 

									
	 MOSSIMO, INC.,

a Delaware corporation
	 		 	 PILLOWTEX HOLDINGS AND MANAGEMENT LLC,

a Delaware limited liability company

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer
			
	 OFFICIAL-PILLOWTEX LLC,

a Delaware limited liability company
	 		 	 SCION BBC LLC,

a Delaware limited liability company

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer
			
	OP HOLDINGS AND MANAGEMENT CORPORATION, a Delaware corporation	 		 	 SCION LLC,

a Delaware limited liability company

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer
			
	 OP HOLDINGS, LLC,

a Delaware limited liability company
	 		 	 SHARPER IMAGE HOLDINGS AND MANAGEMENT CORP.,

a Delaware corporation

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer

 [Signature Page to Third Amendment to Credit Agreement] 

 

 SUBSIDIARY GUARANTORS (continued): 

 

									
	 SHARPER IMAGE HOLDINGS LLC,

a Delaware limited liability company
	 		 	 UMBRO SOURCING LLC,
 a
Delaware limited liability company

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer
			
	 STUDIO HOLDINGS AND MANAGEMENT

CORPORATION, a Delaware corporation
	 		 	 UNZIPPED APPAREL LLC,
 a
Delaware limited liability company

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer
			
	 STUDIO IP HOLDINGS LLC,
 a
Delaware limited liability company
	 		 	 ZY HOLDINGS AND MANAGEMENT 

CORP., a Delaware corporation

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer
			
	 UMBRO IP HOLDINGS LLC,
 a
Delaware limited liability company
	 		 	 LC PARTNERS US, LLC,

a Delaware limited liability company

					
	By:	  	 /s/ David Jones
	 		 	By:	 	 /s/ David Jones

	Name:	  	David Jones	 		 	Name:	 	David Jones
	Title:	  	Chief Financial Officer	 		 	Title:	 	Chief Financial Officer

 [Signature Page to Third Amendment to Credit Agreement] 

 
			
	ADMINISTRATIVE AGENT AND COLLATERAL AGENT:
	
	 CORTLAND CAPITAL MARKET

SERVICES LLC

 
			
		
	By:	 	 /s/ Matthew Tryba

	Name:  	 	 Matthew Tryba

	Title:	 	 Associate Counsel

 
			
	LENDERS:
	
	 DEUTSCHE BANK AG, NEW YORK

BRANCH

 
			
		
	By:	 	 /s/ Fredric R. Rosenberg

	Name:  	 	 Fredric R. Rosenberg

	Title:	 	 Managing Director

		
	By:	 	 /s/ Stephen Wollman

	Name:	 	 Stephen Wollman

	Title:	 	 Managing Director

  

			
	TSCO LENDING FUND ICAV
	
	 Acting by and through its Alternative

Investment Fund Manager
 Orchard Global Asset Management
LLP

 
			
		
	By:	 	 /s/ Andrew Weber

	Name:  	 	 Andrew Weber

	Title:	 	 Partner

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00279-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00279-of-00352.parquet"}]]